Skip to main content
OpenTrials
Completed

NCT Number: NCT02685696

Surgical Site Infection in Caesarean Section Using Alexis O Compared to Metal Retractors

Objective:

To investigate if the use of the newly designed Alexis O Retractor leads to improved intra-operative and post-operative surgical outcomes in the setting of planned elective Caesarean Sections.

Study Design:

This ethically approved study is designed as a prospective, randomized controlled trial in planned, first time Caesarean Sections with 200 patients randomized to either the Alexis-O Retractor group or the conventional group. Patients with wound healing problems, connective tissue disorders, insulin dependent diabetes, bleeding disorders, previous major abdominal surgery and chorioamnionitis are excluded. Outcomes include surgical site infection, intraoperative parameters such as tissue damage, postoperative analgesia requirements and patient satisfaction scores.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Surgical Site Infection Infections Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications Surgical Wound Infection Wound Infection

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

About this study

Main Hypothesis:

Does the use of the newly designed Alexis O Retractor lead to improved Surgical Site Infection rates intra-operative and post-operative surgical outcomes in the setting of planned elective first time Caesarean Sections in patients compared to the traditional self-retaining metal retractor?

Secondary Hypotheses:

Does the Alexis O Retractor lead to improved intra-operative and post-operative surgical outcomes in the setting of planned elective Caesarean Sections?

Study Design:

The Study is designed as a prospective, randomized controlled trial with 100 patients randomized to the Alexis O Retractor group and 100 patients to the conventional group.

All patients will be recruited following a thorough discussion about the purpose and methodology of the study and full documented consent will be obtained prior to randomization.

Patients with wound healing problems, connective tissue disorders, diabetes, bleeding disorders, previous abdominal surgery apart from laparoscopy and chorioamnionitis will be excluded.

All surgical operators are thoroughly trained in the use and application of the Alexis O Retractor prior to the start of the study and supported by regular teaching demonstrations. The Obstetric Theatre Team is informed and trained in use and application of the Alexis O Retractor within the Study Design.

Ethical Approval:

Ethical Approval has already been obtained from the Ethics committee at the Charité University Hospital Committee and in keeping with ethical standards.

Statistics:

  • Data analysis and statistical comparisons will be performed by the appropriate robust statistical methodology.
  • Comparisons to be investigated
  • Subjective Assessment of the Ease of Application of Retractor Instrument
  • Incision to Delivery Time
  • Incision to Skin Suture Time
  • Subjective Assessment of Visualized Operative Field
  • Subjective Assessment of Freedom of Surgical Movement
  • Interference from Descending Bowel or Adnexal Tissue
  • Bowel and Bladder Trauma
  • Need for Bowel Packing
  • Need for Paracolic Cleaning of Blood and Amniotic Fluid
  • Need for Uterus Exteriorization Intraoperatively
  • Fascial Trauma
  • Muscle Trauma
  • Muscle Suturing
  • Coagulation of the Subcutaneous Tissue
  • Subcutaneous Tissue Thickness
  • Skin Lacerations
  • Trauma to the Baby
  • Estimated Blood Loss
  • Ease of Retractor Removal
  • Analgesia Requirements Post Operative
  • Wound Healing Problems on Discharge and at 6 Weeks (Telephone Interview)
  • Wound Infections (As defined by Centers for Disease Control)
  • Time to Hospital Discharge
  • 6-Week Scar Pain Scores (Telephone Interview)
  • Patient Satisfaction with Wound Healing (Telephone Interview)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women
  • Elective Caesarean Section
  • First Caesarean Section

Exclusion criteria

  • Diabetes
  • Chronic auto immune diseases
  • Lupus
  • Immune deficiency diseases
  • HIV
  • known bleeding disorders
  • full anti-coagulation therapy
  • wound healing problems
  • previous Caesarean Section
  • major abdominal surgery
  • laparotomy
  • active phase of labor
  • suspected chorioamnionitis
  • confirmed chorioamnionitis

Treatment and study plan

Alexis O Retractor

Device

A newly developed abdominal wall retractor for Caesarean Section is the Alexis O Ring which is formed of 2 rings and a interconnecting plastic polyurethane sheath where the flexible inner ring is placed into the abdomen and where the rigid outer ring is rolled to create tension on the plastic sheath providing 360° abdominal wound retraction with simultaneously a tamponade effect whilst covering the abdominal wound during the Caesarean Section and delivery of the baby.

Metal Retractor

Device

The traditional self-retaining metal Collins Caesarean Wound Retractor.

Other names: Collins

Primary outcomes

  1. Incidence of surgical site infection in low risk women having a first time planned Caesarean Section using the Alexis O Retractor compared to the traditional Metal Retractor.

    Time frame: 6-8 Weeks after Surgery

Secondary outcomes

  1. Application Satisfaction Scale Scores

    Time frame: Immediate Postoperative

  2. Removal Satisfaction Scale Scores

    Time frame: On the day of Surgery (Day 0)

  3. Post Operative Pain Scale Scores at Discharge

    Time frame: On the day of discharge (3-5 days)

  4. Post Operative Pain at 6 Weeks

    Time frame: 6 weeks post operative

  5. Patients with Wound Dehisence at Discharge

    Time frame: On the day of discharge (3-5 days)

  6. Patients with either open wounds, infected wounds, bleeding wounds or painful wound at 6 Weeks

    Time frame: 6 weeks post operative

  7. Blood Loss Volume

    Time frame: On the day of Surgery (Day 0)

  8. Visual Field Satisfaction Scores

    Time frame: On the day of Surgery (Day 0)

  9. Freedom of Movement Satisfaction Scores

    Time frame: On the day of Surgery (Day 0)

  10. No. Patients with Prolapsing Bowel in the operative field at the time of Caesarean Section

    Time frame: On the day of Surgery (Day 0)

  11. No. of Patients needing repositioning of prolapsing bowel at the time of Caesarean

    Time frame: On the day of Surgery (Day 0)

  12. No. of Patients with bowel injury sustained at the time of Caesarean Section

    Time frame: On the day of Surgery (Day 0)

  13. No. of Patients sustaining bladder injury at the time of Caesarean Section

    Time frame: On the day of Surgery (Day 0)

  14. No. of Patients where bowel packing with abdominal swabs was performed at the time of Caesarean Section

    Time frame: On the day of Surgery (Day 0)

  15. No. of Patients where suction of Blood and Liquor from the parabolic gutters was necessary at the time of Caesarean Section

    Time frame: On the day of Surgery (Day 0)

  16. No. of Patients where the Uterus was exteriorized at the time of Caesarean Section

    Time frame: On the day of Surgery (Day 0)

  17. No. of Patients with Rectus Sheath Fascial Tears at the time of Caesarean Section

    Time frame: On the day of Surgery (Day 0)

  18. No. of Patients with Rectus Muscle Tearing at the time of Caesarean Section

    Time frame: On the day of Surgery (Day 0)

  19. No. of Patients where Rectus Muscle Suturing was performed at the time of Caesarean

    Time frame: On the day of Surgery (Day 0)

  20. No. of Patients where Subcutaneous Electro-Coagulation was performed at the time of Caesarean Section

    Time frame: On the day of Surgery (Day 0)

  21. No. of Patients with lacerations to the skin wound edges at the time of Caesarean Section

    Time frame: On the day of Surgery (Day 0)

  22. No. of Patients where the Baby was cut at the time of Caesarean Section

    Time frame: On the day of Surgery (Day 0)

  23. Wound Healing Satisfaction at 6 Weeks

    Time frame: 6 weeks post operative.

  24. Time to Discharge

    Time frame: 3-5 Days

Sponsors and collaborators

Lead sponsor

Charite University, Berlin, Germany

Other

Registry information

Official study title

To Investigate the Incidence of Surgical Site Infection in Low Risk Women Having a First Time Planned Caesarean Section Using the Alexis O Retractor and the Traditional Metal Retractor

Important dates

Study start
2013
Primary completion
2016
Study completion
2016
First posted
Feb 19, 2016
Registry last updated
Feb 19, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.